PeptidePedia The community reference

Satiety signalling (revision 5)

Old revision·16:34, 27 Sep 2024·RepackRadek

This is an old revision of this page, as it stood at 16:34, 27 Sep 2024, saved by RepackRadek with the summary add the enteroendocrine cell type responsible for secretion. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Satiety signalling
SatiationTermination of a meal in progress
SatietySuppression of intake between meals
Principal relayNucleus of the solitary tract, area postrema
Topic infobox · conventions

Satiety signalling comprises the peripheral signals and central circuits that end a meal and delay the next one. The literature distinguishes satiation — the process terminating an eating episode — from satiety, the inter-meal suppression of appetite; the distinction matters because different signals dominate each.[1]

Peripheral signals include gastric distension relayed by vagal mechanoreceptors, nutrient-sensing hormones from the small intestine such as cholecystokinin, GLP-1, peptide YY and amylin, and longer-term adiposity signals such as leptin and insulin. These converge on the caudal brainstem and on hypothalamic circuits including the arcuate nucleus.[1]

Pharmacological exploitation of this system is what GLP-1 receptor agonists do. They produce a sustained supraphysiological signal in a system evolved for episodic signalling, and the great majority of the weight loss they produce is attributable to reduced energy intake rather than to increased expenditure.[2]

Peripheral signals

[edit]

Gastric distension is the most immediate satiation signal, relayed by vagal afferents in the stomach wall. It is volume-dependent rather than calorie-dependent, which is why delayed gastric emptying produces satiation out of proportion to the nutrient consumed.[1]

Intestinal hormones add nutrient specificity. Cholecystokinin is released from duodenal I cells in response to fat and protein and acts largely within a meal. GLP-1 and peptide YY are released from more distal L cells and act over a longer window. Amylin, co-secreted with insulin from the pancreas, acts at the area postrema.[3]

References

  1. ^ a b c Woods SC. "The control of food intake: behavioral versus molecular perspectives." Cell Metabolism 9(6):489–498 (2009). DOI:10.1016/j.cmet.2009.04.007. PMID 19490904.
  2. ^ Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell Metabolism 27(4):740–756 (2018). PMID 29617641.
  3. ^ Holst JJ. "The physiology of glucagon-like peptide 1." Physiological Reviews 87(4):1409–1439 (2007). PMID 17928588.